Literature DB >> 8027950

An efficient control strategy for dosage regimens.

C Hu1, W S Lovejoy, S L Shafer.   

Abstract

In medical drug therapy, efficient dosage strategies are needed to maintain target drug concentrations. The relationship between the concentration of a drug and the dosages is often described by compartment models in which the parameters are unknown, although prior knowledge may be available and can be updated after blood samples are taken during the therapy. Currently MAP (maximum a posteriori) Bayesian is the most often used control strategy in this setting. We show by simulation in a one-compartment context that the performance of the MAP Bayesian strategy depends on the assumptions in prior distribution of the parameters as well as the cost function. We propose an alternative control strategy, VU, that outperforms and is more robust than the MAP Bayesian strategy in a variety of problem settings.

Mesh:

Substances:

Year:  1994        PMID: 8027950     DOI: 10.1007/bf02353411

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  9 in total

Review 1.  Modeling, adaptive control, and optimal drug therapy.

Authors:  R W Jelliffe; A Schumitzky
Journal:  Med Prog Technol       Date:  1990-05

2.  Population pharmacokinetics of alfentanil: the average dose-plasma concentration relationship and interindividual variability in patients.

Authors:  P O Maitre; S Vozeh; J Heykants; D A Thomson; D R Stanski
Journal:  Anesthesiology       Date:  1987-01       Impact factor: 7.892

3.  Estimates of the population pharmacokinetic parameters and performance of Bayesian feedback: a sensitivity analysis.

Authors:  S Vozeh; C Steiner
Journal:  J Pharmacokinet Biopharm       Date:  1987-10

4.  Forecasting individual pharmacokinetics.

Authors:  L B Sheiner; S Beal; B Rosenberg; V V Marathe
Journal:  Clin Pharmacol Ther       Date:  1979-09       Impact factor: 6.875

5.  A priori lithium dosage regimen using population characteristics of pharmacokinetic parameters.

Authors:  J Gaillot; J L Steimer; A J Mallet; J J Thebault; A Bieder
Journal:  J Pharmacokinet Biopharm       Date:  1979-12

6.  Pharmacokinetics of fentanyl administered by computer-controlled infusion pump.

Authors:  S L Shafer; J R Varvel; N Aziz; J C Scott
Journal:  Anesthesiology       Date:  1990-12       Impact factor: 7.892

7.  Rapid prediction of individual dosage requirements for lignocaine.

Authors:  S Vozeh; M Berger; M Wenk; R Ritz; F Follath
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

8.  Computer-assisted drug assay interpretation based on Bayesian estimation of individual pharmacokinetics: application to lidocaine.

Authors:  S Vozeh; R Hillman; M Wandell; T Ludden; L Sheiner
Journal:  Ther Drug Monit       Date:  1985       Impact factor: 3.681

9.  Bayesian forecasting improves the prediction of intraoperative plasma concentrations of alfentanil.

Authors:  P O Maitre; D R Stanski
Journal:  Anesthesiology       Date:  1988-11       Impact factor: 7.892

  9 in total
  4 in total

1.  Use of a pharmacokinetic/pharmacodynamic model to design an optimal dose input profile.

Authors:  K Park; D Verotta; S K Gupta; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1998-08

2.  Bayesian individualization via sampling-based methods.

Authors:  J Wakefield
Journal:  J Pharmacokinet Biopharm       Date:  1996-02

3.  Comparison of some control strategies for three-compartment PK/PD models.

Authors:  C Hu; W S Lovejoy; S L Shafer
Journal:  J Pharmacokinet Biopharm       Date:  1994-12

4.  Weighted target interval stochastic control methods with global optimization and their applications in individualizing therapy.

Authors:  Shaolin Ji; Yingzhi Zeng; Ping Wu; Edmund Jon Deoon Lee
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-05-12       Impact factor: 2.410

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.